345
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Topical hyaluronan alone promotes corneal epithelial cell migration whereas combination with benzalkonium chloride impairs epithelial wound healing

ORCID Icon, , , , &
Pages 13-20 | Received 22 Apr 2019, Accepted 20 Sep 2019, Published online: 14 Oct 2019

References

  • Weissmann B, Meyer K. The structure of hyalobiuronic acid and of hyaluronic acid from umbilical cord. J Am Chem Soc 1954;76:1753–1757.
  • Fraser JRE, Laurent TC, Laurent U. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 1997;242:27–33.
  • Meyer K, Palmer JW. The polysaccharide of the vitreous humor. J Biol Chem 1934;107:629–634.
  • Meyer K, Smyth EM, Dawson MH. The isolation of a mucopolysaccharide synovial fluid. J Biol Chem 1939;128:319–327.
  • Meyer K, Chaffee E, Hobby GL, et al. Hyaluronidases of bacterial and animal origin. J Exp Med 1941;73:309–326.
  • Aya KL, Stern R. Hyaluronan in wound healing: rediscovering a major player. Wound Repair Regen 2014;22:579–593.
  • Jiang D, Liang J, Noble PW. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 2007;23:435–461.
  • West D, Hampson I, Arnold F, et al. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985;228:1324–1326.
  • Slevin M, Kumar S, Gaffney J. Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem 2002;277:41046–41059.
  • Saikia P, Roychowdhury S, Bellos D, et al. Hyaluronic acid 35 normalizes TLR4 signaling in Kupffer cells from ethanol-fed rats via regulation of microRNA291b and its target Tollip. Sci Rep 2017;7:15671.
  • Bollyky PL, Wu RP, Falk BA, et al. ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors. Proc Natl Acad Sci USA 2011;108:7938–7943.
  • Nishida T, Nakamura M, Mishima H, et al. Hyaluronan stimulates corneal epithelial migration. Exp Eye Res 1990;53:753–758.
  • Kretz FTA, Limberger IJ, Auffarth GU. Corneal endothelial cell coating during phacoemulsification using a new dispersive hyaluronic acid ophthalmic viscosurgical device. J Cataract Refract Surg 2014;40:1879–1884.
  • Sparavigna A, Fino P, Tenconi B, et al. A new dermal filler made of cross-linked and auto-cross-linked hyaluronic acid in the correction of facial aging defects. J Cosmet Dermatol 2014;13:307–314.
  • Palmieri B, Rottigni V, Iannitti T. Preliminary study of highly cross-linked hyaluronic acid-based combination therapy for management of knee osteoarthritis-related pain. Drug Des Devel Ther 2013;7:7–12.
  • Martins M, Azoia NG, Shimanovich U, et al. Design of novel BSA/hyaluronic acid nanodispersions for transdermal pharma purposes. Mol Pharmaceutics 2014;11:1479–1488.
  • Tashiro T, Seino S, Sato T, et al. Oral administration of polymer hyaluronic acid alleviates symptoms of knee osteoarthritis: a double-blind, placebo-controlled study over a 12-month period. Sci World J 2012;2012:167928.
  • Kawada C, Kimura M, Masuda Y, et al. Oral administration of hyaluronan prevents skin dryness and epidermal thickening in ultraviolet irradiated hairless mice. J Photochem Photobiol B Biol 2015;153:215–221.
  • Cagini C, Torroni G, Fiore T, et al. Tear film stability in Sjögren syndrome patients treated with hyaluronic acid versus crosslinked hyaluronic acid-based eye drops. J Ocul Pharmacol Ther 2017;33:539–542.
  • Nakamura M, Hikida M, Nakano T. Concentration and molecular weight dependency of rabbit corneal epithelial wound healing on hyaluronan. Curr Eye Res 1992;11:981–986.
  • Zheng X, Goto T, Shiraishi A, et al. In vitro efficacy of ocular surface lubricants against dehydration. Cornea 2013;32:1260–1264.
  • Nakamura M, Mishima H, Nishida T, et al. Binding of hyaluronan to plasma fibronectin increases the attachment of corneal epithelial cells to a fibronectin matrix. J Cell Physiol 1994;159:415–422.
  • Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II epidemiology report. Ocul Surf 2017;15:334–368.
  • Nagai N, Murao T, Okamoto N, et al. Comparison of corneal wound healing rates after instillation of commercially available latanoprost and travoprost in rat debrided corneal epithelium. J Oleo Sci 2010;59:135–141.
  • Lin Z, Liu X, Zhou T, et al. A mouse dry eye model induced by topical administration of benzalkonium chloride. Mol Vis 2011;17:257–264.
  • Liu X, Yu F-F, Zhong Y-M, et al. Therapeutic effects of sodium hyaluronate on ocular surface damage induced by benzalkonium chloride preserved anti-glaucoma medications. Chin Med J 2015;128:2444–2449.
  • Yu F, Liu X, Zhong Y, et al. Sodium hyaluronate decreases ocular surface toxicity induced by benzalkonium chloride-preserved latanoprost: an in vivo study. Invest Ophthalmol Vis Sci 2013;54:3385–3393.
  • Nagai N, Ito Y, Okamoto N, et al. In vitro evaluation of corneal damages after instillation of eye drops using rat debrided corneal epithelium: changes in corneal damage of benzalkonium chloride by addition of thickening agent. Yakugaku Zasshi 2012;132:837–843.
  • Wu CL, Chou HC, Li JM, et al. Hyaluronic acid-dependent protection against alkali-burned human corneal cells. Electrophoresis 2013;34:1–28.
  • Asada H, Takaoka-Shichijo Y, Nakamura M, et al. Optimization of benzalkonium chloride concentration in 0.0015% Tafluprost ophthalmic solution from the points of ocular surface safety and preservative efficacy. Yakugaku Zasshi 2010;130:867–871.
  • Saika S, Shiraishi A, Liu CY, et al. Role of lumican in the corneal epithelium during wound healing. J Biol Chem 2000;275:2607–2612.
  • Sumioka T, Okada Y, Reinach PS, et al. Impairment of corneal epithelial wound healing in a TRPV1-deficient mouse. Invest Ophthalmol Vis Sci 2014;55:3295–3302.
  • Ayaki M, Iwasawa A, Niwano Y. Cell viability score as an integrated indicator for cytotoxicity of benzalkonium chloride-containing antiglaucoma eyedrops. Biocontrol Sci 2012;17:121–128.
  • Shirai K, Okada Y, Cheon DJ, et al. Effects of the loss of conjunctival Muc16 on corneal epithelium and stroma in mice. Invest Ophthalmol Vis Sci 2014;55:3626–3637.
  • Desbenoit N, Hamm G, Liang H, et al. A new safety concern for glaucoma treatment demonstrated by mass spectrometry imaging of benzalkonium chloride distribution in the eye, an experimental study in rabbits. PLoS One 2012;7:e50180.
  • Tseng C, Hung Y, Chen ZY, et al. Synergistic effect of artificial tears containing epigallocatechin gallate and hyaluronic acid for the treatment of rabbits with dry eye syndrome. PLoS One 2016;11:e0157982.
  • Okada Y, Saika S, Shirai K, et al. JNK MAPK signaling contributes in vivo to injury-induced corneal epithelial migration. Ophthalmic Res 2009;42:185–192.
  • Rönkkö S, Vellonen K, Järvinen K, et al. Human corneal cell culture models for drug toxicity studies. Drug Deliv and Transl Res 2016;6:660–675.
  • Denion E, Charlot F, Béraud G. A 5-minute interval between two dilating eye drops increases their effect. Optom Vis Sci 2017;94:838–844.
  • Salzillo R, Schiraldi C, Corsuto L, et al. Optimization of hyaluronan-based eye drop formulations. Carbohydr Polym 2016;153:275–283.
  • Campo GM, D’Ascola A, Avenoso A, et al. Glycosaminoglycans reduce oxidative damage induced by copper (Cu + 2), iron (Fe + 2) and hydrogen peroxide (H2O2) in human fibroblast cultures. Glycoconj J 2003;20:133–141.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.